A schema summarizing the molecular mechanism of tamoxifen in sensitive ER-negative breast cancer cells is presented in Figure 4D. Tamoxifen inhibited CIP2A, restored PP2A activity and led to p-Akt downregulation and cancer cell apoptosis (Figure 4D). This evidence concerns the gene PTPA and cancer.